Companies / Apogee Therapeutics, Inc. / Activity
Activity — Apogee Therapeutics, Inc.
49 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 22, 2026 | Fairmount Funds Management LLC Director | Sell | Common Stock | $133.53M | -1.8M -85.42% | 298,647 0.39% of shares | high |
| Jan 7, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $1.15M | -15K -6.49% | 213,449 0.28% of shares | medium |
| Aug 5, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $737.9K | -6K -3.16% | 168,498 0.22% of shares | medium |
| Feb 11, 2026 | Henderson Michael Thomas CEO | Sell | Common Stock | $723.7K | -11K -0.96% | 1,181,493 1.56% of shares | medium |
| Jan 14, 2026 | Henderson Michael Thomas CEO | Sell | Common Stock | $676.6K | -8K -0.70% | 1,203,071 1.59% of shares | medium |
| Mar 11, 2026 | Henderson Michael Thomas CEO | Sell | Common Stock | $621.3K | -8K -0.71% | 1,164,624 1.54% of shares | medium |
| Mar 11, 2026 | Henderson Michael Thomas CEO | Sell | Common Stock | $615.0K | -8K -0.71% | 1,156,405 1.53% of shares | medium |
| Feb 11, 2026 | Henderson Michael Thomas CEO | Sell | Common Stock | $481.2K | -8K -0.64% | 1,173,942 1.55% of shares | medium |
| Jan 14, 2026 | Henderson Michael Thomas CEO | Sell | Common Stock | $447.9K | -5K -0.45% | 1,193,457 1.58% of shares | medium |
| Jan 7, 2026 | Dambkowski Carl Executive | Exercise | Common Stock | $320.6K | +14K +6.46% | 231,223 0.31% of shares | low |
| Jan 2, 2026 | Henderson Jane Executive | Sell | Common Stock | $306.8K | -4K -2.13% | 187,371 0.25% of shares | medium |
| Mar 11, 2026 | Henderson Michael Thomas CEO | Sell | Common Stock | $259.3K | -3K -0.30% | 1,152,987 1.52% of shares | medium |
| Jan 7, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $227.8K | -3K -1.28% | 228,269 0.30% of shares | medium |
| Mar 4, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $226.8K | -3K -1.50% | 212,048 0.28% of shares | medium |
| Jan 14, 2026 | Henderson Michael Thomas CEO | Sell | Common Stock | $192.3K | -2K -0.20% | 1,200,697 1.59% of shares | medium |
| Mar 25, 2026 | Henderson Jane Executive | Sell | Common Stock | $170.0K | -2K -1.10% | 179,371 0.24% of shares | medium |
| Feb 4, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $161.0K | -2K -1.15% | 214,167 0.28% of shares | medium |
| Jan 6, 2026 | Henderson Jane Executive | Sell | Common Stock | $160.0K | -2K -1.07% | 185,371 0.24% of shares | medium |
| Jan 14, 2026 | Henderson Michael Thomas CEO | Sell | Common Stock | $152.8K | -2K -0.15% | 1,198,843 1.58% of shares | medium |
| Mar 4, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $149.4K | -2K -0.98% | 209,973 0.28% of shares | medium |
| Jan 2, 2026 | Henderson Jane Executive | Sell | Common Stock | $142.3K | -2K -0.99% | 191,451 0.25% of shares | medium |
| Jan 14, 2026 | Henderson Michael Thomas CEO | Sell | Common Stock | $113.2K | -1K -0.12% | 1,211,547 1.60% of shares | medium |
| Mar 4, 2026 | Dambkowski Carl Executive | Exercise | Common Stock | $94.3K | +4K +1.95% | 215,273 0.28% of shares | low |
| Feb 4, 2026 | Dambkowski Carl Executive | Exercise | Common Stock | $94.3K | +4K +1.94% | 216,648 0.29% of shares | low |
| Aug 5, 2026 | Dambkowski Carl Executive | Exercise | Common Stock | $94.3K | +4K +2.43% | 173,998 0.23% of shares | low |
| Feb 4, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $93.5K | -1K -0.66% | 212,747 0.28% of shares | low |
| Feb 4, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $86.8K | -1K -0.61% | 211,448 0.28% of shares | low |
| Feb 2, 2026 | Henderson Jane Executive | Sell | Common Stock | $73.3K | -1K -0.60% | 183,471 0.24% of shares | low |
| Mar 2, 2026 | Henderson Jane Executive | Sell | Common Stock | $70.0K | -994 -0.54% | 181,777 0.24% of shares | low |
| Jan 7, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $65.3K | -826 -0.39% | 212,623 0.28% of shares | low |
| Feb 11, 2026 | Henderson Michael Thomas CEO | Sell | Common Stock | $62.1K | -955 -0.08% | 1,172,987 1.55% of shares | low |
| Feb 2, 2026 | Henderson Jane Executive | Sell | Common Stock | $51.6K | -792 -0.43% | 184,579 0.24% of shares | low |
| Jan 14, 2026 | Henderson Michael Thomas CEO | Sell | Common Stock | $39.4K | -470 -0.04% | 1,192,987 1.58% of shares | low |
| Mar 2, 2026 | Henderson Jane Executive | Sell | Common Stock | $29.1K | -406 -0.22% | 181,371 0.24% of shares | low |
| Mar 2, 2026 | Henderson Jane Executive | Sell | Common Stock | $20.8K | -300 -0.16% | 182,771 0.24% of shares | low |
| Mar 2, 2026 | Henderson Jane Executive | Sell | Common Stock | $20.5K | -300 -0.16% | 183,071 0.24% of shares | low |
| Mar 4, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $14.7K | -200 -0.10% | 209,773 0.28% of shares | low |
| Feb 4, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $13.8K | -200 -0.09% | 211,148 0.28% of shares | low |
| Jan 7, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $8.0K | -100 -0.05% | 212,523 0.28% of shares | low |
| Feb 4, 2026 | Dambkowski Carl Executive | Sell | Common Stock | $6.8K | -100 -0.05% | 211,348 0.28% of shares | low |
| Feb 2, 2026 | Henderson Jane Executive | Sell | Common Stock | $6.7K | -100 -0.05% | 183,371 0.24% of shares | low |
| Jun 9, 2026 | Jones William a Jr Director | Grant | Stock Option (Right to Buy) | — | +8K | 7,657 0.01% of shares | low |
| Mar 4, 2026 | Dambkowski Carl Executive | Exercise | Stock Option (Right to Buy) | — | -4K -3.05% | 131,290 0.17% of shares | low |
| Feb 4, 2026 | Dambkowski Carl Executive | Exercise | Stock Option (Right to Buy) | — | -4K -2.96% | 135,415 0.18% of shares | low |
| Jan 7, 2026 | Dambkowski Carl Executive | Exercise | Stock Option (Right to Buy) | — | -14K -9.13% | 139,540 0.18% of shares | low |
| Jan 2, 2026 | Dambkowski Carl Executive | Grant | Stock Option (Right to Buy) | — | +84K | 83,690 0.11% of shares | low |
| Jan 2, 2026 | Henderson Michael Thomas CEO | Grant | Stock Option (Right to Buy) | — | +253K | 253,016 0.33% of shares | low |
| Jan 2, 2026 | Henderson Jane Executive | Grant | Stock Option (Right to Buy) | — | +84K | 83,690 0.11% of shares | low |
| Aug 5, 2026 | Dambkowski Carl Executive | Exercise | Stock Option (Right to Buy) | — | -4K -3.59% | 110,665 0.15% of shares | low |